FDA Issues Warning to Best Chinese Medicines LLC
Federal regulators flagged five unapproved herbal products marketed with unauthorized medical claims online.
Updated on Oct. 27, 2026 in Healthcare
Live Poll
Should herbal supplements marketed for treating diseases be regulated as strictly as pharmaceutical drugs?
The Food and Drug Administration issued a warning letter to Best Chinese Medicines LLC for marketing five herbal products with unapproved medical claims. Regulators determined that the items were being sold as drugs to treat conditions including hypertension, Covid-19, and arthritis.
Why it matters
The FDA conducts such reviews to fulfill its public health mandate to protect consumers from potentially unsafe, ineffective, or poor-quality drugs that lack formal approval. These oversight actions ensure that products marketed for serious illnesses meet established federal safety and efficacy standards.
The company has 15 business days to provide a written response to the FDA regarding the violations cited in warning letter 738556. The agency identified five products as unapproved new drugs following a review conducted in September 2026.
The players
Food and Drug Administration
The federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.
Best Chinese Medicines LLC
A company based in Lake Kiowa, TX, that sells herbal products through its website.
The details
The FDA identified the products Dissolve Mass Stasis Breaker, Gynostemma Leaf, Wenxin Keli, Lianhua Qingwen Capsules, and Duhuo Jisheng Wan during a review of bestchinesemedicines.com. Because these items were marketed to treat or cure diseases, they are legally classified as drugs that require formal application and approval.
Timeline
The FDA conducted a review of the company's website in September 2026.
The official FDA warning letter was issued on October 23, 2026.
The company must submit a written response within 15 business days of receiving the notice.
Market Landscape
The FDA's enforcement action follows the regulatory framework established by the Federal Food, Drug, and Cosmetic Act. This action highlights the broader oversight of the online supplement and herbal medicine market to ensure consumer protection against unauthorized medical claims.
Consumers should be aware that the identified products lack FDA approval for treating medical conditions like hypertension or Covid-19. Shoppers should consult healthcare providers before using products that make unverified medical claims regarding serious health issues.
The takeaway
Consumers should verify whether health products have been approved by federal regulators before relying on them to treat specific medical conditions. Always discuss new supplements or herbal treatments with a qualified physician to ensure they are safe and appropriate for your health needs.
Further reading
Learn more about the federal oversight of Healthcare products in the United States.
More information
Review the official FDA warning letter for full details on the violations.
Source note: This article includes information reported by U.S. Food and Drug Administration.
Live Poll
Should herbal supplements marketed for treating diseases be regulated as strictly as pharmaceutical drugs?
